The utility of molecular testing in colorectal cancer: The promise needs progress

Nilofer S. Azad, Luis A. Diaz

Research output: Contribution to journalArticle

Abstract

Molecularly profiling colorectal cancer has opened many potential opportunities for the use of this information in therapeutic decision-making. However, at present, only RAS testing in the metastatic setting has a definitive place in the decision-making paradigm.

Original languageEnglish (US)
JournalONCOLOGY (United States)
Volume28
Issue number2
StatePublished - Feb 15 2014

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'The utility of molecular testing in colorectal cancer: The promise needs progress'. Together they form a unique fingerprint.

  • Cite this